Docs
All documentation Fundamental API Live (Delayed) API EOD Historical API Intraday API Real-Time (websockets) API Google Sheets add-on Excel add-on
Community
Academy 134 articles Forum Github 13 repos
Marketplace
Spreadsheets
Google Sheets add-on Excel add-on Wordpress plugin
Pricing
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. NASDAQ /
  3. PACB.NASDAQ

Pacific Biosciences of California (PACB NASDAQ) stock market data APIs

$2 -0.14(-6.6%) as of July 26, 2024
Price chart is built with Anychart

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing solution to resolve genetically complex problems. The company provides sequencing systems; consumable products, including single molecule real-time (SMRT) technology; long-red sequencing; and various reagent kits designed for specific workflow, such as preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. In addition, it provides revio system + sequel systems which conduct, monitor, and analyze single-molecule biochemical reactions in real time; SBB short-read sequencing; onso instrument conducts, monitors, and analyzes SBB biochemical reactions; and SBB consumable, including flow cells, clustering, and sequencing reagent kits. The company serves academic and governmental research institutions; commercial testing and service laboratories; genome centers; public health labs, hospitals and clinical research institutes, and contract research organizations; pharmaceutical companies; and agricultural companies. It markets its products through a sales force and distribution partners in Asia, Australia, Europe, the Middle East, Africa, and Latin America. It has a development and commercialization agreement with Invitae Corporation; and a collaboration with Radboud University Medical to explore genetic causes of rare and genetic diseases. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.

Pacific Biosciences of California Financial Data Overview

2.135
2
-
2.18
1.96
1.16-13.67
519 M
272 M
200 M
-0.29
2.043
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'PACB',
Type: 'Common Stock',
Name: 'Pacific Biosciences of California',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000QKXH20',
ISIN: NULL,
CUSIP: NULL,
CIK: '1299130',
EmployerIdNumber: '16-1590339',
FiscalYearEnd: 'December',
IPODate: '2010-10-27',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Medical Devices',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Pacific Biosciences of California Fundamental Data is available in our Financial Data APIs

  • Net Revenue 200 M
  • EBITDA -282 536 992
  • Earnings Per Share -1.14
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Pacific Biosciences of California Earnings via APIs

  • Latest Release 2024-05-09
  • EPS/Forecast -0.28

Get Pacific Biosciences of California End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Pacific Biosciences of California latest news via APIs

Novogene to Power Cancer, Rare Disease, and Environmental Research with PacBio Sequencing

PacBio Highly accurate long-read sequencing data will be used at Novogene’s new lab in Munich, supporting customers across a network of leading research institutions MENLO PARK, Calif., July 23, 2...

PacBio to Report Second Quarter 2024 Financial Results on August 7, 2024

PacBio MENLO PARK, Calif., July 15, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its second quarter 2024 financial results...
Do you have any questions?
support@eodhistoricaldata.com